Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

109,415 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ITPRIPL1 binds CD3ε to impede T cell activation and enable tumor immune evasion.
Deng S, Zhang Y, Wang H, Liang W, Xie L, Li N, Fang Y, Wang Y, Liu J, Chi H, Sun Y, Ye R, Shan L, Shi J, Shen Z, Wang Y, Wang S, Brosseau JP, Wang F, Liu G, Quan Y, Xu J. Deng S, et al. Among authors: wang h, wang f, wang y, wang s. Cell. 2024 Apr 25;187(9):2305-2323.e33. doi: 10.1016/j.cell.2024.03.019. Epub 2024 Apr 12. Cell. 2024. PMID: 38614099
[Awareness and Influencing Factors of Clinical Trial Among Cancer Patients in China].
Huang H, Fang Y, Fang H, Wu D, Bai Y, Wang S, Yu A, Wang H, Sun C, Fan Q, Yu Y, Yang C, Shi J, He R, Li N. Huang H, et al. Among authors: wang h, wang s. Zhongguo Fei Ai Za Zhi. 2020 Jan 20;23(1):5-14. doi: 10.3779/j.issn.1009-3419.2020.01.02. Zhongguo Fei Ai Za Zhi. 2020. PMID: 31948532 Free PMC article. Chinese.
[Acceptance and Related Causes of Clinical Trials among Cancer Patients in China].
Huang H, Fan Q, Fang H, Wu D, Wang S, Bai Y, Yu A, Wang H, Sun C, Yu Y, Fang Y, Yang S, Shi J, He R, Li N. Huang H, et al. Among authors: wang h, wang s. Zhongguo Fei Ai Za Zhi. 2020 Jan 20;23(1):41-49. doi: 10.3779/j.issn.1009-3419.2020.01.07. Zhongguo Fei Ai Za Zhi. 2020. PMID: 31948537 Free PMC article. Chinese.
Availability of anticancer biosimilars in 40 countries.
Huang HY, Wu DW, Ma F, Liu ZL, Shi JF, Chen X, Wang SH, Fang H, Bai Y, Yu Y, Fang Y, Sun C, Fan Q, Wu Y, Fan RH, Zhou CY, He BX, Dai M, Li N, Xu BH, Sun Y, He J. Huang HY, et al. Lancet Oncol. 2020 Feb;21(2):197-201. doi: 10.1016/S1470-2045(19)30860-5. Lancet Oncol. 2020. PMID: 32007192 No abstract available.
Clinical development of immuno-oncology in China.
Wu DW, Huang HY, Tang Y, Zhao Y, Yang ZM, Wang J, Wang SH, Yu Y, Fang Y, Fang H, Bai Y, Sun C, Fan Q, Yu AQ, Wang HL, Du CX, Chen K, Huang MD, Zhang Y, Li N, Xu BH, Sun Y, He J. Wu DW, et al. Lancet Oncol. 2020 Aug;21(8):1013-1016. doi: 10.1016/S1470-2045(20)30329-6. Lancet Oncol. 2020. PMID: 32758460 No abstract available.
The Landscape of Cell and Gene Therapies for Solid Tumors.
Wang S, Sun F, Huang H, Chen K, Li QJ, Zhang L, Wang E, Wang C, Zhang H, Yuan AQ, Chen B, Deng T, Liu Y, Sun J, Liu D, Yu Y, Fang Y, Jiang N, Wu D, Fang H, Bai Y, Xing S, Ni Y, Fan Q, Yu A, Sun C, Tang Y, Li N, Xu B, He J. Wang S, et al. Among authors: wang e, wang c. Cancer Cell. 2021 Jan 11;39(1):7-8. doi: 10.1016/j.ccell.2020.12.005. Cancer Cell. 2021. PMID: 33434513 Free article. No abstract available.
Pharmacoeconomic Evaluation of Cancer Biosimilars Worldwide: A Systematic Review.
Huang HY, Liu CC, Yu Y, Wang L, Wu DW, Guo LW, Wang SH, Fang H, Bai Y, Fang Y, Fan Q, Sun C, Wu Y, Shi JF, Ma F, Tang Y, Dai M, Li N. Huang HY, et al. Front Pharmacol. 2020 Nov 12;11:572569. doi: 10.3389/fphar.2020.572569. eCollection 2020. Front Pharmacol. 2020. PMID: 33536905 Free PMC article. Review.
109,415 results
You have reached the last available page of results. Please see the User Guide for more information.